SLC1A5 and glioma: Akt pathway also regulates Oct4 and Sox2 expression, which are essential transcription factors for maintaining the self‐renewal of cancer stem cells.[50] We speculate that the upregulation of SLC1A5 is only one of the pathways by which the COL1‐CD133 interaction enhances the properties of glioma stem cells.